A Phase 2A, Open Label, Proof-of-Concept Trial of Daxdilimab for the Treatment of Moderate-to-Severe Alopecia Areata Register Today!
Alopecia Areata – HZNP-DAX-201
Read More
Maternal-Infant Research on Environmental Chemicals (Mirec-Endo – Phase II)
A study to determine whether prenatal exposure to elevated levels of various environmental chemicals, as well as other in-utero factors are related to the onset and progression of puberty, child metabolic function and growth. Click here for more information. Register Today!
Clinical Research Coordinator
Caitlyn Van Zon
About Caitlyn We’ll tell you very soon!
Obesity – I8F-MC-GPIJ
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Effect of Tirzepatide on the Reduction of Morbidity and Mortality in Adults with Obesity Register Today!
Atopic Dermatitis – ACT17207
A Phase 2, randomized, double-blind, placebo controlled, multicenter proof-of-concept study evaluating efficacy and safety of rilzabrutinib in adult patients with moderate-to-severe atopic dermatitis who are inadequate responders or intolerant to topical corticosteroids. Register Today!
Christine Garceau
About Christine We’ll tell you very soon!
Plaque Psoriasis – (ME3183-3)
Phase 2a Study to Assess the Efficacy and Safety of ME3183 Administered Orally in Subjects with Moderate to Severe Plaque Psoriasis Register Today!</a
IED Vaccine in Adults – VAC52416BAC3001
Phase 3 Study to Assess the Efficacy, Safety And Immunogenicity of Vaccination With ExPEC9V in the Prevention of Invasive Extraintestinal Pathogenic Escherichia coli Disease in Adults Aged 60 Years And Older with a History of Urinary Tract Infection in the Past 2 Years Register Today!
Meibomian Gland Dysfunction (MGD) and Evaporative Dry Eye Disease (DED) AZ201801
A Multicenter, Vehicle-controlled, Randomized Study to Evaluate the Safety, Tolerability, Systemic Pharmacokinetics, and Pharmacodynamics of AZR-MD-001 in Patients with Meibomian Gland Dysfunction (MGD) and Evaporative Dry Eye Disease (DED) Register Today!